3711 related articles for article (PubMed ID: 7456419)
41. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
42. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
43. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
Vollmer RT; Seigler HF
Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
[TBL] [Abstract][Full Text] [Related]
44. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
45. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
46. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
47. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic significance of the morphological traits of skin melanoma of the head and neck].
Parshikova SM; Ragimov IR
Arkh Patol; 1985; 47(9):74-81. PubMed ID: 4074159
[TBL] [Abstract][Full Text] [Related]
49. [Prognostic histopathological features of cutaneous malignant melanomas. New statistical approach (author's transl)].
Le Doussal V; Brunet M; Guérin P; Hacène K; Lasry S; Marcotorchino F; Michaud P; Hébert H
Ann Pathol; 1981; 1(2):130-9. PubMed ID: 7284057
[TBL] [Abstract][Full Text] [Related]
50. [Malignant melanoma: prognostic evaluation using correlation coefficients].
Kühnl-Petzoldt C; Berger H; Wiebelt H
Hautarzt; 1983 Aug; 34(8):398-402. PubMed ID: 6618884
[TBL] [Abstract][Full Text] [Related]
51. Guidelines of prognostics in malignant skin melanoma.
Lukács L
Acta Chir Hung; 1988; 29(1):43-51. PubMed ID: 3394458
[TBL] [Abstract][Full Text] [Related]
52. Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma.
Int J Cancer; 1980 Dec; 26(6):733-9. PubMed ID: 7216542
[TBL] [Abstract][Full Text] [Related]
53. [New viewpoints on the prognostic index in malignant melanomas].
Keller D; Hundeiker M
Z Hautkr; 1985 Feb; 60(3):279-82. PubMed ID: 3993143
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.
Lee YT
Ann Surg; 1980 Jan; 191(1):87-97. PubMed ID: 7352783
[TBL] [Abstract][Full Text] [Related]
55. [The malignant melanoma: criteria for the prognosis and therapy].
Nagel GA; Rufli T
Schweiz Med Wochenschr; 1978 Sep; 108(35):1355-9. PubMed ID: 684397
[TBL] [Abstract][Full Text] [Related]
56. [Malignant melanoma in life insurance--thickness or anatomic layer?].
Müller WA; Erlanger M
Versicherungsmedizin; 1994 Dec; 46(6):193-5. PubMed ID: 7825264
[TBL] [Abstract][Full Text] [Related]
57. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
[TBL] [Abstract][Full Text] [Related]
58. Prognostic histopathological factors in malignant melanoma.
Shaw HM; Balch CM; Soong SJ; Milton GW; McCarthy WH
Pathology; 1985 Apr; 17(2):271-4. PubMed ID: 4047730
[TBL] [Abstract][Full Text] [Related]
59. Stage I melanoma of the skin: the problem of resection margins. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma.
Eur J Cancer (1965); 1980 Aug; 16(8):1079-85. PubMed ID: 7439222
[No Abstract] [Full Text] [Related]
60. Some remarks to the histological classification of malignant melanoma of the skin and its prognostic values.
Svejda J; Mechl Z; Rejthar A
Neoplasma; 1977; 24(4):425-30. PubMed ID: 904746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
